Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia J Biondi

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
American Family Physician|December 15, 2022
Simplification in Hepatitis C TreatmentMia J Biondi, Cheryl Dale
Canadian Liver Journal|August 22, 2022
Hepatitis C models of care: approaches to eliminationMia J Biondi, Jordan J Feld
Hepatology Communications|April 13, 2026
DAAs in pregnancy are the only potential intervention to decrease vertical transmission: Pregnancy DAA data support safetyCatherine Chappell, Mia J Biondi, Tatyana Kushner
Canadian Liver Journal|March 20, 2024
Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrowFaranak Canani, Jordan J Feld, Mia J Biondi
Journal of the American Association of Nurse Practitioners|January 23, 2022
Nurse practitioners as primary care site champions for the screening and treatment of hepatitis C virusCheryl H Dale, Elizabeth Smith, Mia J Biondi
Paediatrics & Child Health|September 8, 2025
Striving for universal birth dose hepatitis B vaccination in Canada: data from Ontario make a compelling caseMia J Biondi, Jennifer van Gennip, Jordan J Feld
Viruses|January 21, 2023
Hepatitis B and C in Pregnancy and Children: A Canadian PerspectiveAndrew B Mendlowitz, Jordan J Feld, Mia J Biondi
Microorganisms|November 27, 2024
Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led SolutionsKate P R Dunn, Mia J Biondi, Samuel S Lee
BMJ Global Health|April 10, 2026
Strengthening the hepatitis B care cascade to prevent vertical transmission in Africa: a call to empower midwivesJuliet Abredu, Karen Campbell, Jordan J Feld, et al.
The Journal of Biological Chemistry|June 10, 2010
N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiationMia J Biondi, Greg L Beilhartz, Suzanne McCormick, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
American Family Physician|December 15, 2022
Simplification in Hepatitis C TreatmentMia J Biondi, Cheryl Dale
Canadian Liver Journal|August 22, 2022
Hepatitis C models of care: approaches to eliminationMia J Biondi, Jordan J Feld
Hepatology Communications|April 13, 2026
DAAs in pregnancy are the only potential intervention to decrease vertical transmission: Pregnancy DAA data support safetyCatherine Chappell, Mia J Biondi, Tatyana Kushner
Canadian Liver Journal|March 20, 2024
Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrowFaranak Canani, Jordan J Feld, Mia J Biondi
Journal of the American Association of Nurse Practitioners|January 23, 2022
Nurse practitioners as primary care site champions for the screening and treatment of hepatitis C virusCheryl H Dale, Elizabeth Smith, Mia J Biondi
Paediatrics & Child Health|September 8, 2025
Striving for universal birth dose hepatitis B vaccination in Canada: data from Ontario make a compelling caseMia J Biondi, Jennifer van Gennip, Jordan J Feld
Viruses|January 21, 2023
Hepatitis B and C in Pregnancy and Children: A Canadian PerspectiveAndrew B Mendlowitz, Jordan J Feld, Mia J Biondi
Microorganisms|November 27, 2024
Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led SolutionsKate P R Dunn, Mia J Biondi, Samuel S Lee
BMJ Global Health|April 10, 2026
Strengthening the hepatitis B care cascade to prevent vertical transmission in Africa: a call to empower midwivesJuliet Abredu, Karen Campbell, Jordan J Feld, et al.
The Journal of Biological Chemistry|June 10, 2010
N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiationMia J Biondi, Greg L Beilhartz, Suzanne McCormick, et al.
Pageof 7